Every patient responds differently to treatment. But treating with EXTAVIA may be beneficial to you for these reasons:
- EXTAVIA has been shown to decrease the number of relapses
- EXTAVIA has been shown to help reduce the risk of having a second episode within 2 years in patients with CIS
- EXTAVIA has been shown to decrease the number of new MRI lesions and reduce the size of existing MRI lesions
In studies of people taking interferon beta-1b, it has been shown that with this therapy you may:
- Experience a slower rate of relapse
- Experience fewer episodes of new or worsening symptoms
- Experience fewer days of moderate and severe relapsing symptoms
The importance of early treatment
If you've had one episode and MRI findings consistent with MS, EXTAVIA can help reduce your risk of having another clinical attack.
In patients who have had one episode and whose MRI findings are consistent with MS, EXTAVIA has been shown to reduce the risk of having a second clinical attack within 2 years.






Side Effects of EXTAVIA


